NYSE · SI
Healthcare · Medical - Specialties
$19.13
Down-$1.31 (-6.41%)
Updated Nov 1, 2026, 11:32 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SI
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
SI closed at $19.13 after 20 trading sessions, down 2.40% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $20.50 | $20.74 | $19.05 | $19.13 | 119.32K |
| Oct 29, 2026 | $19.76 | $20.45 | $19.20 | $20.44 | 144.83K |
| Oct 28, 2026 | $19.30 | $20.15 | $18.56 | $19.48 | 55.94K |
| Oct 27, 2026 | $19.31 | $20.16 | $19.31 | $19.34 | 135.92K |
| Oct 26, 2026 | $19.60 | $19.60 | $19.00 | $19.38 | 71.6K |
| Oct 23, 2026 | $19.50 | $19.90 | $19.275 | $19.66 | 67.34K |
| Oct 22, 2026 | $19.34 | $20.03 | $19.34 | $19.75 | 57.97K |
| Oct 21, 2026 | $18.65 | $20.45 | $18.65 | $19.34 | 154.74K |
| Oct 20, 2026 | $18.53 | $19.03 | $18.30 | $18.72 | 67.59K |
| Oct 19, 2026 | $17.99 | $18.8677 | $17.84 | $18.25 | 67.8K |
| Oct 16, 2026 | $18.52 | $18.59 | $18.05 | $18.09 | 61.63K |
| Oct 15, 2026 | $18.20 | $18.998 | $18.20 | $18.37 | 81.02K |
| Oct 14, 2026 | $18.10 | $18.61 | $17.87 | $17.87 | 104.06K |
| Oct 13, 2026 | $18.25 | $18.95 | $17.955 | $18.07 | 69.13K |
| Oct 12, 2026 | $18.30 | $18.40 | $17.97 | $18.23 | 69.15K |
| Oct 9, 2026 | $17.75 | $18.635 | $17.75 | $18.13 | 90.99K |
| Oct 8, 2026 | $18.70 | $19.015 | $17.795 | $17.89 | 100.91K |
| Oct 7, 2026 | $19.27 | $19.325 | $18.495 | $18.71 | 81.76K |
| Oct 6, 2026 | $19.56 | $19.91 | $19.03 | $19.14 | 126.98K |
| Oct 5, 2026 | $18.81 | $20.03 | $18.74 | $19.60 | 148.09K |
The latest Smart Investors Daily articles mentioning SI.
Company
Market Activity
Research & News
SI research
Company profile and research snapshot.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2026 | BTIG | Buy | — |
| Aug 10, 2026 | UBS | Buy | — |
| Aug 7, 2026 | Piper Sandler | Overweight | — |
| Aug 7, 2026 | BTIG | Buy | — |
| Jul 28, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 27, 2026
Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the following upcoming investor conferences:
Yahoo · Oct 24, 2026
Investing.com - Silver faces near-term turbulence as central banks maintain monetary policy pressure, but prices are poised to reach $80 an ounce by late 2027 amid expanding artificial intelligence infrastructure demand and persistent structural supply deficits, according to a research note from UBS Global Wealth Management.
Yahoo · Oct 15, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2026 after market close on Thursday, November 5, 2026.
Benzinga · Oct 12, 2026
On Thursday, Shoulder Innovations (NYSE:SI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SI.
